Macleods Pharmaceuticals Ltd — Rosuvastatin Exporter Profile
Indian Pharmaceutical Exporter · #12 for Rosuvastatin · $8.4M export value · DGFT Verified
Macleods Pharmaceuticals Ltd is the #12 Indian exporter of Rosuvastatin with $8.4M in export value and 207 verified shipments. Macleods Pharmaceuticals Ltd holds a 1.8% market share in Rosuvastatin exports across 19 countries.
Macleods Pharmaceuticals Ltd — Rosuvastatin Export Profile: Buyers & Destinations
Where Does Macleods Pharmaceuticals Ltd Export Rosuvastatin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| POLAND | $2.6M | 115 | 51.6% |
| FRANCE | $932.2K | 36 | 18.8% |
| SAUDI ARABIA | $447.0K | 30 | 9.0% |
| SOUTH AFRICA | $381.2K | 29 | 7.7% |
| KUWAIT | $206.7K | 8 | 4.2% |
| CANADA | $137.2K | 18 | 2.8% |
| PAKISTAN | $63.4K | 5 | 1.3% |
| BARBADOS | $46.1K | 7 | 0.9% |
| HONG KONG | $30.8K | 5 | 0.6% |
| KENYA | $28.7K | 7 | 0.6% |
Macleods Pharmaceuticals Ltd exports Rosuvastatin to 22 countries. The largest destination is POLAND accounting for 51.6% of Macleods Pharmaceuticals Ltd's Rosuvastatin shipments, followed by FRANCE (18.8%) and SAUDI ARABIA (9.0%). These destinations reflect Macleods Pharmaceuticals Ltd's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Rosuvastatin from Macleods Pharmaceuticals Ltd?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| SYNOPTIS INDUSTRIAL SP .ZO.O | POLAND | $1.5M | 68 |
| PLANETPHARMA | FRANCE | $837.7K | 33 |
| SYNOPTIS INDUSTRIAL SP Z O O | POLAND | $743.5K | 29 |
| MACLEODS PHARMACEUTICALS SA (PTY) | SOUTH AFRICA | $281.4K | 18 |
| ALRAI PHARMACEUTICAL INDUSTRIES CO | SAUDI ARABIA | $169.8K | 10 |
| SYNOPTIS INDUSTRIAL SP ZO O | POLAND | $167.9K | 6 |
| SAUDI PHARMACEUTICALS INDUSTRIES | SAUDI ARABIA | $155.7K | 6 |
| MINT PHARMACEUTICALS INC | CANADA | $137.2K | 18 |
| ALRAI PHARMACEUTICAL INDUSTRIES, CO | SAUDI ARABIA | $102.9K | 8 |
| SYNOPTIS INDUSTRIAL SP ZO.O. | POLAND | $97.6K | 7 |
Macleods Pharmaceuticals Ltd supplies Rosuvastatin to 41 buyers globally. The largest buyer is SYNOPTIS INDUSTRIAL SP .ZO.O (POLAND), followed by PLANETPHARMA (FRANCE) and SYNOPTIS INDUSTRIAL SP Z O O (POLAND). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Rosuvastatin Export Value and How Much Does Macleods Pharmaceuticals Ltd Contribute?
India exported $321.1M worth of Rosuvastatin through 13,477 shipments from 427 suppliers to 143 countries, serving 1,314 buyers globally. Macleods Pharmaceuticals Ltd contributes $8.4M to this total, accounting for 1.8% of India's Rosuvastatin exports. Macleods Pharmaceuticals Ltd ships Rosuvastatin to 22 countries through 41 buyers.
What Is the Average Shipment Value for Macleods Pharmaceuticals Ltd's Rosuvastatin Exports?
Macleods Pharmaceuticals Ltd's average Rosuvastatin shipment value is $40.4K per consignment, based on 207 shipments totaling $8.4M. The largest destination is POLAND (51.6% of Macleods Pharmaceuticals Ltd's Rosuvastatin exports).
How Does Macleods Pharmaceuticals Ltd Compare to Other Indian Rosuvastatin Exporters?
Macleods Pharmaceuticals Ltd ranks #12 among 427 Indian Rosuvastatin exporters with a 1.8% market share. The top 3 exporters are MSN LABORATORIES PRIVATE LIMITED ($58.9M), GLENMARK PHARMACEUTICALS LIMITED ($44.3M), BIOCON PHARMA LIMITED ($32.6M). Macleods Pharmaceuticals Ltd processed 207 shipments to 19 destination countries.
What Rosuvastatin Formulations Does Macleods Pharmaceuticals Ltd Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| ROSUMAC 20MG CPR B/30(ROSUVASTATIN TABLE | $228.0K | 8 |
| ROSUMAC 10 CPR B/30(ROSUVASTATIN TABLETS | $219.7K | 5 |
| EXORTA 10 MG 28 TABL (ROSUVASTATIN 10 MGTABLETS)BNO. 14250022A & 14250025A MFGDT:01/2025 EXP DT:12/2027 PS: 4X7S | $150.0K | 3 |
| EXORTA 10 MG 28 TABL (ROSUVASTATIN 10 MG | $135.5K | 3 |
| EXORTA 5 MG 28 TABL (ROSUVASTATIN 5 MG TABLETS)BNO. 14250105A TO 14250109A MD. 01/25 ED. 12/27 PS: 4X7S | $117.3K | 3 |
| ROZTOR 20 (ROSUVASTATIN TABLETS 20 MG), | $85.3K | 3 |
| ROSUMAC 10MG CPR B/30(ROSUVASTATINTABLETS 10 MG) 3X10'S (19426 PAC)TBS | $76.3K | 3 |
| ROSUMAC 20MG CPR B/30(ROSUVASTATINTABLETS 20 MG) 3X10'S (11950 PAC)TBS | $75.1K | 3 |
| VASROV (ROSUVASTATIN) 20MG TABLETS BNO:B | $68.8K | 4 |
| RASTOR 40 ROSUVASTATIN FILM COATED 40MG | $56.6K | 2 |
Macleods Pharmaceuticals Ltd exports 193 distinct Rosuvastatin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ROSUMAC 20MG CPR B/30(ROSUVASTATIN TABLE with 8 shipments worth $228.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
How Does Macleods Pharmaceuticals Ltd Compare to Nearest Rosuvastatin Exporters?
Exporters ranked immediately above and below #12 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 11 | HETERO LABS LIMITED | $11.7M | 239 | 10 | $48.9K |
| 9 | AUROBINDO PHARMA LIMITED | $10.7M | 213 | 6 | $50.0K |
| 12 | MACLEODS PHARMACEUTICALS LTD ★ | $8.4M | 207 | 19 | $40.4K |
| 13 | APOTEX RESEARCH PRIVATE LIMITED | $7.8M | 155 | 2 | $50.0K |
| 14 | AJANTA PHARMA LIMITED | $6.5M | 155 | 13 | $42.2K |
Macleods Pharmaceuticals Ltd ranks #12 among 427 Indian Rosuvastatin exporters. Average shipment value of $40.4K compared to the market average of $751.9K. The closest competitors by value are HETERO LABS LIMITED and AUROBINDO PHARMA LIMITED.
Which Indian Ports Ship Rosuvastatin Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 1,090 | 8.1% |
| SAHAR AIR | 921 | 6.8% |
| SAHAR AIR CARGO ACC (INBOM4) | 909 | 6.7% |
| HYDERABAD ICD (INSNF6) | 878 | 6.5% |
| DELHI AIR CARGO ACC (INDEL4) | 769 | 5.7% |
| JNPT/ NHAVA SHEVA SEA | 699 | 5.2% |
| DELHI AIR | 635 | 4.7% |
| HYDERABAD ICD | 550 | 4.1% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Rosuvastatin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Rosuvastatin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Macleods Pharmaceuticals Ltd matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 297 individual customs records matching Macleods Pharmaceuticals Ltd exporting Rosuvastatin, covering 193 formulations to 22 countries via 41 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 143+ countries, 1,314+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Rosuvastatin Export Data from Macleods Pharmaceuticals Ltd
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Macleods Pharmaceuticals Ltd's Rosuvastatin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Macleods Pharmaceuticals Ltd
Company Profile
0 products · $0 total trade · 0 categories
Rosuvastatin Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Macleods Pharmaceuticals Ltd.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Rosuvastatin. For current shipment-level data, contact TransData Nexus.